Morning Briefing
Summaries of health policy coverage from major news organizations
Study: Most Teens With Long Covid Recover After 2 Years
Most teenagers who have suffered from long Covid recover within two years, according to the largest study of its kind. But the researchers said more work was needed to understand why some children still had ongoing health problems two years after infection. (12/4)
Â鶹ŮÓÅ Health News: Nursing Homes Fell Behind On Vaccinating Patients For Covid
It seems no one is taking covid-19 seriously anymore, said Mollee Loveland, a nursing home aide who lives outside Pittsburgh. ... Between her patients’ complex medical needs and their close proximity to one another, covid continues to pose a grave threat to Loveland’s nursing home — and to the 15,000 other certified nursing homes in the U.S. where some 1.2 million people live. Despite this risk, a CDC report published in April found that just 4 in 10 nursing home residents in the U.S. received an updated covid vaccine in the winter of 2023-24. (Boden, 12/4)
The debate continues over how covid started —
A preliminary analysis takes a closer look at genomic data collected at the market. A preliminary analysis takes a closer look at genomic data collected at the market. (Mallapaty, 12/4)
A congressional subcommittee concluded its two-year investigation on the coronavirus pandemic on Monday, finding that COVID-19 likely originated from a lab in Wuhan, China, and that social distancing and masking were not backed with scientific data. (Sorace, 12/2)
On RSV and flu —
Cases of flu and respiratory syncytial virus (RSV) are ticking up across the United States even as overall respiratory virus activity remains low. Flu activity is increasing slightly among children while RSV activity is elevated in the southern, central and eastern U.S., according to data updated Monday from the Centers for Disease Control and Prevention. As of the week ending Nov. 23, the latest date for which data is available, 0.6% of emergency department visits were for flu and 0.4% were for RSV. (Kekatos and Benadjaoud, 12/3)